{"pmid":32346873,"title":"Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.","text":["Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.","Few studies reported the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients with completely asymptomatic throughout the disease course. We investigated the epidemiological and clinical features of patients infected by SARS-CoV-2 without any symptoms. Patients with confirmed SARS-CoV-2 infection were retrospectively recruited. The demographic characteristics, clinical data, treatment, and outcomes of SARS-CoV-2 infected patients without any symptoms were analyzed. Fifteen (4.4%) of 342 SARS-CoV-2 infected patients did not develop any symptom during the course of the disease. The median time from exposure to diagnosis was 7.0 days (IQR 1.0-15.0 days). Of the 15 patients, 14 patients were diagnosed by tested positive for SARS-CoV-2 in throat swabs, while 1 patient was only tested positive for SARS-CoV-2 in anal swabs. During hospitalization, only 1 (6.7%) patient developed lymphopenia. Abnormalities of chest CT examinations were detected in 8 (53.4%) patients on admission. As of March 8, 2020, all patients have been discharged. The median time of SARS-CoV-2 tested negative from admission was 7.0 days (IQR 4.0-9.0 days). Patients without any symptoms but with SARS-CoV-2 exposure should be closely monitored and tested for SARS-CoV-2 both in anal and throat swabs to excluded the infection. Asymptomatic patients infected by SARS-CoV-2 have favorable outcomes. This article is protected by copyright. All rights reserved.","J Med Virol","Xu, Tianmin","Huang, Rui","Zhu, Li","Wang, Jian","Cheng, Juan","Zhang, Biao","Zhao, Haiyan","Chen, Kang","Shao, Huaping","Zhu, Chuanwu","Wu, Chao","Liu, Longgen","32346873"],"abstract":["Few studies reported the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients with completely asymptomatic throughout the disease course. We investigated the epidemiological and clinical features of patients infected by SARS-CoV-2 without any symptoms. Patients with confirmed SARS-CoV-2 infection were retrospectively recruited. The demographic characteristics, clinical data, treatment, and outcomes of SARS-CoV-2 infected patients without any symptoms were analyzed. Fifteen (4.4%) of 342 SARS-CoV-2 infected patients did not develop any symptom during the course of the disease. The median time from exposure to diagnosis was 7.0 days (IQR 1.0-15.0 days). Of the 15 patients, 14 patients were diagnosed by tested positive for SARS-CoV-2 in throat swabs, while 1 patient was only tested positive for SARS-CoV-2 in anal swabs. During hospitalization, only 1 (6.7%) patient developed lymphopenia. Abnormalities of chest CT examinations were detected in 8 (53.4%) patients on admission. As of March 8, 2020, all patients have been discharged. The median time of SARS-CoV-2 tested negative from admission was 7.0 days (IQR 4.0-9.0 days). Patients without any symptoms but with SARS-CoV-2 exposure should be closely monitored and tested for SARS-CoV-2 both in anal and throat swabs to excluded the infection. Asymptomatic patients infected by SARS-CoV-2 have favorable outcomes. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Xu, Tianmin","Huang, Rui","Zhu, Li","Wang, Jian","Cheng, Juan","Zhang, Biao","Zhao, Haiyan","Chen, Kang","Shao, Huaping","Zhu, Chuanwu","Wu, Chao","Liu, Longgen"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346873","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/jmv.25944","keywords":["asymptomatic","coronavirus disease 2019","severe acute respiratory syndrome coronavirus 2"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665441658345357312,"score":8.599203,"similar":[{"pmid":32318703,"title":"Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers.","text":["Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers.","BACKGROUND: We retrospectively analysed 26 persistently asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carriers. METHODS: Epidemiological and clinical characteristics from the 26 asymptomatic patients with positive results for SARS-CoV-2 RNA testing were obtained. RESULTS: Twenty-two patients (84.6%) correlated with clustering occurrence. The median period from contact to diagnosis and the last positive nucleic acid test was 19 (8-24 days) and 21.5 days (10-36 days), respectively. The median period from diagnosis to negative nucleic acid test was significantly different between patients with normal or atypical chest computed tomography (CT) findings (n=16, 61.5%; 7.5 days [2-20 days]) and patients with typical ground-glass or patchy opacities on CT(n=10, 38.5%; 12.5 days[8-22 days]; P<0.01). Seven patients (70.0%) with initial positive nucleic acid test results had a negative result simultaneously with improved CT findings. Obvious improvement in CT findings was observed in three patients (30.0%) despite positive nucleic acid test results. CONCLUSION: In asymptomatic patients, changes in biochemical and inflammatory variables are small and changes on chest CT can occur. It is worth noting the long existence of SARS-CoV-2 in some asymptomatic patients and false-negative results need to be considered in SARS-CoV-2nucleic acid test.","J Infect Dis","Pan, Yanfeng","Yu, Xue","Du, Xinwei","Li, Qingqing","Li, Xianyang","Qin, Tao","Wang, Miaomiao","Jiang, Minlin","Li, Jie","Li, Weiguo","Zhang, Qian","Xu, Zhiwei","Zhang, Lu","32318703"],"abstract":["BACKGROUND: We retrospectively analysed 26 persistently asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carriers. METHODS: Epidemiological and clinical characteristics from the 26 asymptomatic patients with positive results for SARS-CoV-2 RNA testing were obtained. RESULTS: Twenty-two patients (84.6%) correlated with clustering occurrence. The median period from contact to diagnosis and the last positive nucleic acid test was 19 (8-24 days) and 21.5 days (10-36 days), respectively. The median period from diagnosis to negative nucleic acid test was significantly different between patients with normal or atypical chest computed tomography (CT) findings (n=16, 61.5%; 7.5 days [2-20 days]) and patients with typical ground-glass or patchy opacities on CT(n=10, 38.5%; 12.5 days[8-22 days]; P<0.01). Seven patients (70.0%) with initial positive nucleic acid test results had a negative result simultaneously with improved CT findings. Obvious improvement in CT findings was observed in three patients (30.0%) despite positive nucleic acid test results. CONCLUSION: In asymptomatic patients, changes in biochemical and inflammatory variables are small and changes on chest CT can occur. It is worth noting the long existence of SARS-CoV-2 in some asymptomatic patients and false-negative results need to be considered in SARS-CoV-2nucleic acid test."],"journal":"J Infect Dis","authors":["Pan, Yanfeng","Yu, Xue","Du, Xinwei","Li, Qingqing","Li, Xianyang","Qin, Tao","Wang, Miaomiao","Jiang, Minlin","Li, Jie","Li, Weiguo","Zhang, Qian","Xu, Zhiwei","Zhang, Lu"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32318703","week":"202017|Apr 20 - Apr 26","doi":"10.1093/infdis/jiaa205","keywords":["coronavirus disease 2019","severe acute respiratory syndrome coronavirus 2","asymptomatic","clinical characteristics"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664815087797403648,"score":235.32407},{"pmid":32294504,"pmcid":"PMC7152865","title":"CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.","text":["CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.","PURPOSE: Aimed to characterize the CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia. METHODS: Asymptomatic cases with COVID-19 pneumonia confirmed by SARS-COV-2 nucleic acid testing in Renmin Hospital of Wuhan University were retrospectively enrolled. The characteristics of CT imaging and clinical feature were collected and analyzed. RESULTS: 58 asymptomatic cases with COVID-19 pneumonia admitted to our hospital between Jan 1, 2020 and Feb 23, 2020 were enrolled. All patients had history of exposure to SARS-CoV-2. On admission, patients had no symptoms and laboratory findings were normal. The predominant feature of CT findings in this cohort was ground glass opacity (GGO) (55, 94.8%) with peripheral (44, 75.9%) distribution, unilateral location (34, 58.6%) and mostly involving one or two lobes (38, 65.5%), often accompanied by characteristic signs. After short-term follow-up, 16 patients (27.6%) presented symptoms with lower lymphocyte count and higher CRP, mainly including fever, cough and fatigue. The evolution of lesions on CT imaging were observed in 10 patients (17.2%). The average days of hospitalization was19.80+/-10.82 days, and was significantly longer in progression patients (28.60+/-7.55 day). CONCLUSION: CT imaging of asymptomatic cases with COVID-19 pneumonia has definite characteristics. Since asymptomatic infections as \"covert transmitter\", and some patients can progress rapidly in the short term. It is essential to pay attention to the surveillance of asymptomatic patients with COVID-19. CT scan has great value in screening and detecting patients with COVID-19 pneumonia, especially in the highly suspicious, asymptomatic cases with negative nucleic acid testing.","J Infect","Meng, Heng","Xiong, Rui","He, Ruyuan","Lin, Weichen","Hao, Bo","Zhang, Lin","Lu, Zilong","Shen, Xiaokang","Fan, Tao","Jiang, Wenyang","Yang, Wenbin","Li, Tao","Chen, Jun","Geng, Qing","32294504"],"abstract":["PURPOSE: Aimed to characterize the CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia. METHODS: Asymptomatic cases with COVID-19 pneumonia confirmed by SARS-COV-2 nucleic acid testing in Renmin Hospital of Wuhan University were retrospectively enrolled. The characteristics of CT imaging and clinical feature were collected and analyzed. RESULTS: 58 asymptomatic cases with COVID-19 pneumonia admitted to our hospital between Jan 1, 2020 and Feb 23, 2020 were enrolled. All patients had history of exposure to SARS-CoV-2. On admission, patients had no symptoms and laboratory findings were normal. The predominant feature of CT findings in this cohort was ground glass opacity (GGO) (55, 94.8%) with peripheral (44, 75.9%) distribution, unilateral location (34, 58.6%) and mostly involving one or two lobes (38, 65.5%), often accompanied by characteristic signs. After short-term follow-up, 16 patients (27.6%) presented symptoms with lower lymphocyte count and higher CRP, mainly including fever, cough and fatigue. The evolution of lesions on CT imaging were observed in 10 patients (17.2%). The average days of hospitalization was19.80+/-10.82 days, and was significantly longer in progression patients (28.60+/-7.55 day). CONCLUSION: CT imaging of asymptomatic cases with COVID-19 pneumonia has definite characteristics. Since asymptomatic infections as \"covert transmitter\", and some patients can progress rapidly in the short term. It is essential to pay attention to the surveillance of asymptomatic patients with COVID-19. CT scan has great value in screening and detecting patients with COVID-19 pneumonia, especially in the highly suspicious, asymptomatic cases with negative nucleic acid testing."],"journal":"J Infect","authors":["Meng, Heng","Xiong, Rui","He, Ruyuan","Lin, Weichen","Hao, Bo","Zhang, Lin","Lu, Zilong","Shen, Xiaokang","Fan, Tao","Jiang, Wenyang","Yang, Wenbin","Li, Tao","Chen, Jun","Geng, Qing"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294504","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jinf.2020.04.004","keywords":["asymptomatic","computed tomography","coronavirus disease 2019(covid-19)","ground glass opacity","sars-cov-2"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1665420446577721346,"score":192.74377},{"pmid":32125362,"pmcid":"PMC7054855","title":"Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.","text":["Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.","Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China. Objective: To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management. Design, Setting, and Participants: Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020. Exposures: Confirmed SARS-CoV-2 infection. Main Outcomes and Measures: Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. Results: Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results. Conclusions and Relevance: Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.","JAMA","Young, Barnaby Edward","Ong, Sean Wei Xiang","Kalimuddin, Shirin","Low, Jenny G","Tan, Seow Yen","Loh, Jiashen","Ng, Oon-Tek","Marimuthu, Kalisvar","Ang, Li Wei","Mak, Tze Minn","Lau, Sok Kiang","Anderson, Danielle E","Chan, Kian Sing","Tan, Thean Yen","Ng, Tong Yong","Cui, Lin","Said, Zubaidah","Kurupatham, Lalitha","Chen, Mark I-Cheng","Chan, Monica","Vasoo, Shawn","Wang, Lin-Fa","Tan, Boon Huan","Lin, Raymond Tzer Pin","Lee, Vernon Jian Ming","Leo, Yee-Sin","Lye, David Chien","32125362"],"abstract":["Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China. Objective: To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management. Design, Setting, and Participants: Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020. Exposures: Confirmed SARS-CoV-2 infection. Main Outcomes and Measures: Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. Results: Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results. Conclusions and Relevance: Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent."],"journal":"JAMA","authors":["Young, Barnaby Edward","Ong, Sean Wei Xiang","Kalimuddin, Shirin","Low, Jenny G","Tan, Seow Yen","Loh, Jiashen","Ng, Oon-Tek","Marimuthu, Kalisvar","Ang, Li Wei","Mak, Tze Minn","Lau, Sok Kiang","Anderson, Danielle E","Chan, Kian Sing","Tan, Thean Yen","Ng, Tong Yong","Cui, Lin","Said, Zubaidah","Kurupatham, Lalitha","Chen, Mark I-Cheng","Chan, Monica","Vasoo, Shawn","Wang, Lin-Fa","Tan, Boon Huan","Lin, Raymond Tzer Pin","Lee, Vernon Jian Ming","Leo, Yee-Sin","Lye, David Chien"],"date":"2020-03-04T11:00:00Z","year":2020,"_id":"32125362","week":"202010|Mar 02 - Mar 08","doi":"10.1001/jama.2020.3204","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"locations":["Wuhan","China","China","Singapore","Singapore","Singapore","Singapore"],"countries":["China","Singapore"],"countries_codes":["CHN|China","SGP|Singapore"],"e_drugs":["lopinavir-ritonavir drug combination"],"_version_":1664640875006787585,"score":191.69852},{"pmid":32161968,"pmcid":"PMC7108162","title":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias.","text":["A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias.","BACKGROUND: A novel coronavirus (2019-nCoV) has raised world concern since it emerged in Wuhan Hubei China in December, 2019. The infection may result into severe pneumonia with clusters illness onsets. Its impacts on public health make it paramount to clarify the clinical features with other pneumonias. METHODS: Nineteen 2019-nCoV pneumonia (NCOVID-19) and fifteen other pneumonia patients (NON-NCOVID-19) in out of Hubei places were involved in this study. Both NCOVID-19 and NON-NCOVID-19 patients were confirmed to be infected in throat swabs or/and sputa with or without 2019-nCoV by real-time RT-PCR. We analyzed the demographic, epidemiological, clinical, and radiological features from those patients, and compared the difference between NCOVID-19 and NON-NCOVID-19. RESULTS: All patients had a history of exposure to confirmed case of 2019-nCoV or travel to Hubei before illness. The median duration, respectively, was 8 (IQR:6~11) and 5 (IQR:4~11) days from exposure to onset in NCOVID-19 and NON-NCOVID-19. The clinical symptoms were similar between NCOVID-19 and NON-NCOVID-19. The most common symptoms were fever and cough. Fifteen (78.95%) NCOVID-19 but 4 (26.67%) NON-NCOVID-19 patients had bilateral involvement while 17 (89.47%) NCOVID-19 but 1 (6.67%) NON-NCOVID-19 patients had multiple mottling and ground-glass opacity of chest CT images. Compared to NON-NCOVID-19, NCOVID-19 present remarkably more abnormal laboratory tests including AST, ALT, gamma-GT, LDH and alpha-HBDH. CONCLUSION: The 2019-nCoV infection caused similar onsets to other pneumonias. CT scan may be a reliable test for screening NCOVID-19 cases. Liver function damage is more frequent in NCOVID-19 than NON-NCOVID-19 patients. LDH and alpha-HBDH may be considerable markers for evaluation of NCOVID-19.","Clin Infect Dis","Zhao, Dahai","Yao, Feifei","Wang, Lijie","Zheng, Ling","Gao, Yongjun","Ye, Jun","Guo, Feng","Zhao, Hui","Gao, Rongbao","32161968"],"abstract":["BACKGROUND: A novel coronavirus (2019-nCoV) has raised world concern since it emerged in Wuhan Hubei China in December, 2019. The infection may result into severe pneumonia with clusters illness onsets. Its impacts on public health make it paramount to clarify the clinical features with other pneumonias. METHODS: Nineteen 2019-nCoV pneumonia (NCOVID-19) and fifteen other pneumonia patients (NON-NCOVID-19) in out of Hubei places were involved in this study. Both NCOVID-19 and NON-NCOVID-19 patients were confirmed to be infected in throat swabs or/and sputa with or without 2019-nCoV by real-time RT-PCR. We analyzed the demographic, epidemiological, clinical, and radiological features from those patients, and compared the difference between NCOVID-19 and NON-NCOVID-19. RESULTS: All patients had a history of exposure to confirmed case of 2019-nCoV or travel to Hubei before illness. The median duration, respectively, was 8 (IQR:6~11) and 5 (IQR:4~11) days from exposure to onset in NCOVID-19 and NON-NCOVID-19. The clinical symptoms were similar between NCOVID-19 and NON-NCOVID-19. The most common symptoms were fever and cough. Fifteen (78.95%) NCOVID-19 but 4 (26.67%) NON-NCOVID-19 patients had bilateral involvement while 17 (89.47%) NCOVID-19 but 1 (6.67%) NON-NCOVID-19 patients had multiple mottling and ground-glass opacity of chest CT images. Compared to NON-NCOVID-19, NCOVID-19 present remarkably more abnormal laboratory tests including AST, ALT, gamma-GT, LDH and alpha-HBDH. CONCLUSION: The 2019-nCoV infection caused similar onsets to other pneumonias. CT scan may be a reliable test for screening NCOVID-19 cases. Liver function damage is more frequent in NCOVID-19 than NON-NCOVID-19 patients. LDH and alpha-HBDH may be considerable markers for evaluation of NCOVID-19."],"journal":"Clin Infect Dis","authors":["Zhao, Dahai","Yao, Feifei","Wang, Lijie","Zheng, Ling","Gao, Yongjun","Ye, Jun","Guo, Feng","Zhao, Hui","Gao, Rongbao"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32161968","week":"202011|Mar 09 - Mar 15","doi":"10.1093/cid/ciaa247","keywords":["clinical features","infectious diseases","novel coronavirus pneumonia","respiratory infection"],"source":"PubMed","topics":["Mechanism","Diagnosis"],"weight":1,"locations":["Wuhan Hubei","China","Hubei","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874786586624,"score":188.25372},{"pmid":32330305,"title":"SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.","text":["SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.","PURPOSE: The purpose of this study was to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, February 19, 2020). RESULTS: SARS-CoV-2 RNA was present in all 4 specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, e.g., the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS-CoV-2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis. This article is protected by copyright. All rights reserved.","J Med Virol","Peng, Liang","Liu, Jing","Xu, Wenxiong","Luo, Qiumin","Chen, Dabiao","Lei, Ziying","Huang, Zhanlian","Li, Xuejun","Deng, Keji","Lin, Bingliang","Gao, Zhiliang","32330305"],"abstract":["PURPOSE: The purpose of this study was to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, February 19, 2020). RESULTS: SARS-CoV-2 RNA was present in all 4 specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, e.g., the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS-CoV-2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Peng, Liang","Liu, Jing","Xu, Wenxiong","Luo, Qiumin","Chen, Dabiao","Lei, Ziying","Huang, Zhanlian","Li, Xuejun","Deng, Keji","Lin, Bingliang","Gao, Zhiliang"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330305","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25936","keywords":["sars-cov-2","prognosis","real-time polymerase chain reaction","specimens","urine"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665420537608798208,"score":183.70651}]}